Articles tagged "Outcome"

2018 American Transplant Congress
Kidney Transplant Outcome in the Patients with Lupus Nephritis
Y. Kim,¹ H. Lee,¹ H. Chin,² Y. Kim,^3,4 S. Han.¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ²Internal Medicine, Seoul National University Bundang Hopsital, Seong-Nam, Republic of Korea; ³Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea; ⁴Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.
Background: Despite improvements in overall prognosis in lupus nephritis, 10%-30% of patients with proliferative renal involvement progress to end stage renal disease, and kidney transplantation…
2018 American Transplant Congress
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis
X. Huang,² N. Joshi,¹ L. Luo,¹ G. Mitri,³ B. Lovelace,² A. Pham,³ X. Gao.¹
¹Pharmerit International, Bethesda, MD; ²Mallinckrodt Pharmaceuticals, Bedminster, NJ; ³Formerly of Mallinckrodt Pharmaceuticals, Bedminster, NJ.
Extracorporeal Photopheresis (ECP) is a cell-based immunomodulatory therapeutic procedure reimbursable by the Centers for Medicare and Medicaid Services for patients with chronic Graft versus Host…
2018 American Transplant Congress
Enhanced Recovery after Kidney Transplantation Regardless of Donor Organ Source
O. Ojogho,¹ S. BaniHani,¹ S. Nemr,¹ B. Dieter,² A. Joyce,¹ J. Mejia.¹
¹Providence Sacred Heart Medical Center and Children's Hospital, Spokane, WA; ²Providence Health Care, Spokane, WA.
BACKGROUND: Enhanced recovery after kidney transplantation is a desired outcome with potential value-enhancing benefits of reduced length of stay (LOS), costs, and risk of nosocomial…
2018 American Transplant Congress
Reliability of Bronchiolitis Obliterans Syndrome Reporting to the OPTN
R. Carrico,¹ R. Lehman,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
¹United Network for Organ Sharing, Richmond; ²Univ of Michigan, Ann Arbor; ³Medical Univ of South Carolina, Charleston.
Background: Chronic rejection of the lung allograft is traditionally classified as bronchiolitis obliterans syndrome (BOS) diagnosed by obstructive airway physiology. The OPTN requires the reporting…
2018 American Transplant Congress
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort
C. Barnhill,¹ P. Warner,² A. Weiss,¹ C. Kuhr,¹ N. Cowan,¹ J. Brandenberger.¹
¹Transplant, Virginia Mason Medical Center, Seattle; ²Immunogenetics/HLA Laboratory, Bloodworks Northwest, Seattle.
With the longest wait times and lowest rate of transplantation, ABO type B renal transplant candidates are at a disadvantage when compared to their type…
2018 American Transplant Congress
New SLK Allocation Policy May Impact Transplant Outcomes in Women
G. Cullaro,¹ R. Hirose,² J. Lai.¹
¹Medicine, University of California, San Francisco, San Francisco, CA; ²Transplant Surgery, University of California, San Francisco, San Francisco, CA.
Background: Previous SLK allocation was based on serum creatinine(Cr), a metric that disadvantaged women(W) relative to men(M). A SLK policy change utilizes eGFR, which accounts…
2018 American Transplant Congress
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry
S. Sanoff,¹ K. Ravindra,¹ W. Irish.^1,2
¹Duke University Medical Center, Durham, NC; ²CTI Consulting, Raleigh, NC.
Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…
2018 American Transplant Congress
Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation
A. L'Huillier,¹ V. Ferreira,¹ C. Hirzel,¹ E. Cordero,² A. Limaye,³ G. Reid,⁴ J. Englund,³ E. Blumberg,⁵ A. Humar,¹ D. Kumar.¹
¹UHN, Toronto, Canada; ²REIPI, Seville, Spain; ³UOWMC, Seattle; ⁴LUMC, Chicago; ⁵UPenn, Philadelphia.
Background:Influenza infection in transplant patients can be severe but factors predictive of outcome in this setting are unclear. The aim of the study was to…
2018 American Transplant Congress
A Calculator for Kidney Transplant Waitlist Outcomes under the New Kidney Allocation System
A. Hart,^1,2 N. Salkowski,² A. Matas,³ B. Kasiske,² J. Snyder,² A. Israni.²
¹HCMC, Minneapolis; ²SRTR, Minneapolis; ³Univ of Minnesota, Minneapolis.
BACKGROUND: Outcomes on the kidney transplant waiting list vary markedly by region and patient characteristics, and the new kidney allocation system (KAS) changed the probability…
2018 American Transplant Congress
Efficacy and Safety of Tocilizumab in Treatment of Acute Antibody Mediated Rejection
K. Venkatachalam, D. Reem, M. Andrew, R. Delos Santos, T. Alhamad.
Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Ohio State University, Columbus, OH; Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Washington University, Saint Louis, MO.
Antibody mediated rejection continues to be one of the most detrimental complications of kidney transplant. Multiple therapeutic strategies focused on B cell and/or HLA antibody…